4FADB,4F-ADB, - Versionsgeschichte

CaroleHoller04 am 4. Juni 2026 um 08:55 Uhr

2026-06-04T08:55:53Z

DianeDevries am 4. Juni 2026 um 08:55 Uhr

2026-06-04T08:55:35Z

ScarlettCagle66 am 4. Juni 2026 um 08:53 Uhr

2026-06-04T08:53:45Z

CaroleHoller04 am 1. Juni 2026 um 17:20 Uhr

2026-06-01T17:20:26Z

DianeDevries am 30. Mai 2026 um 18:46 Uhr

2026-05-30T18:46:28Z

ScarlettCagle66: Die Seite wurde neu angelegt: „Taken together these data further confirmed the structure elucidation of B16. The precursor ion m/z 276 (B1) detected, which was 74 Da lower than that for the…“

2026-05-30T18:35:33Z

Die Seite wurde neu angelegt: „Taken together these data further confirmed the structure elucidation of B16. The precursor ion m/z 276 (B1) detected, which was 74 Da lower than that for the…“

Neue Seite

Taken together these data further confirmed the structure elucidation of B16. The precursor ion m/z 276 (B1) detected, which was 74 Da lower than that for the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicated N-dealkylation of B22. The precursor ion m/z 348 and product ion detected at m/z 217 (B2) identified was 2 Da less than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicating oxidative defluorination (loss of fluorine with addition of hydroxy [https://cannabinoidsrc4f-adb.com/ JWH-210 powder] group Effects of individual doses were compared to the vehicle control value using a priori contrasts. Response-rate data were analyzed by one-way repeated-measure analysis of variance. Percent drug-appropriate responding was shown only if at JWH-210 powder least three rats completed the first fixed ratio, whereas all rats are shown for the response rate dat Acute kidney damage and even kidney failure have been reported following use of synthetic cannabinoids (Davidson, et al., 2017). One recent study has looked at other mechanisms of action in some of the older synthetic cannabinoids and reported that some produced varying amounts of activity at sites which are related to cardiotoxicity and heart disease (Wiley et al., 2016). It is not known whether the increased toxicity is due only to activation of CB1 cannabinoid receptors more strongly than Δ9-THC or whether these "super-strength" cannabinoids produce effects at other receptors. A major cause of concern is that some of the more recently seen synthetic cannabinoids are more likely to produce extremely toxic effects than the older synthetics (Tai and Fantegrossi, 2017 Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during the test session were excluded from the analysis of the discriminative stimulus effects of that dose of test compoun A total of 2 and 3 methamphetamine treated mice fell from the spinning rod 30 min and 2 hr after the administration, respectively. After the first injection, 6 mice of the positive control group (methamphetamine, 5 mg/kg, i.p.) showed loss of traction, of which 4 showed tremor. Most of the abnormalities were normalized in synthetic cannabinoid treated mice although those abnormal behaviors remained in methamphetamine treated animals after 2 hr of administration. Brain samples were prepared from the mice after the last administration of test substance Legal status Briefly, the FOB test was comprised of several behavioral changes including catalepsy, traction, tremor, convulsion, exopthalmos, piloerection, salivation, lacrimation, diarrhea, skin coloration, pinna reflex, righting reflex, and death. The FOB test was performed using published procedures (Moser et al., 1989) with some modifications. However, because of their subjective properties, it is necessary to set up a more objective automated measurement to determine their neurotoxicity. However, there are only a couple of anecdotal reports suspecting the possibility of their neurotoxicity with no scientific evidence (Cohen et al., 2012; McGuinness and Newell, 2012; Harris and Brown, 2013; Hermanns et al., 2013 Separation of compounds was performed on a 2.1 mm×100 mm, 1.7 JWH-210 powder μm particle size ACQUITY Torus™ DIOL analytical column (Waters) with guard cartridge. Measurements were performed by an ACQUITY UPC2 supercritical fluid chromatography system (Waters) coupled with a Xevo TQ-S Triple Quadrupole Mass Spectrometer (Waters). During the death scene examination, multiple cigarette butts without filters were found in an ashtray; also found were alcohol bottles, an unopened box of nebivolol-containing drug, and 18 g of unrecognizable herbal residue in a cigarette box. Data concerning the combined effects of SCRAs and other substances are highly limited, which renders forensic evaluation of possible overdose cases difficult . The threshold SCRA concentration for fatal overdose can be estimated ng/mL level (0.37–4.1 ng/mL according to the reported cases) in cases in which 1.5–2.5 g/L of ethanol is present in the blood. The victims were brothers who were both found deceased after consuming 4F-MDMB-BINACA and ethanol. These confusing shorter names were not scientifically adopted but were used by websites selling the drugs to the public. Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples. This article does not contain any studies with human participants or animals performed by any of the author LC-QTOF-MS represents a significant advancement in the field of drug detection, offering higher sensitivity, specificity, and a broader spectrum of detectable substances. Despite all negative results in the point-of-care test for recreational drugs, the liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) analysis showed that the liquid of the e-cigarette contained ADB-BUTINACA, a synthetic cannabinoid. We report a 27-year-old man who was admitted to the emergency room because of sudden JWH-210 powder headache, nausea, vertigo, red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection is not commonly available. Data availability When clinical presentation and/or initial DOA testing results are inconclusive, additional testing with LC-QTOF-MS can be valuable and is recommended. SCRAs and other NPS may not be detected by point-of-care DOA tests. In this case, the point-of-care DOA urine screening was not able to detect the synthetic cannabinoid ADB-BUTINAC

← Nächstältere Version		Version vom 4. Juni 2026, 08:55 Uhr
Zeile 1:		Zeile 1:
−	~~Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in~~ the ~~present study. Pretreatment times~~ and ~~dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice~~. ~~Average potency of the discriminative stimulus effects of early compounds~~ was ~~0.81±0.17 mg/kg~~ (~~Gatch~~ et al., ~~2014~~), ~~whereas the potency~~ of ~~a recent set was 0.09±0.03 mg/kg (Gatch et al.~~, ~~2018), and the potency of the current~~ set ~~is 0.05±0.01 mg/kg~~. ~~Short-onset~~, ~~short-acting compounds have~~ a ~~greater abuse liability, and long-acting compounds pose problems~~ of ~~long-acting adverse effects and interactions with other drugs. The duration~~ of ~~action of the synthetic cannabinoids tested using the 8-h protocol have varied widely,~~ with ~~some producing a duration of action~~ no ~~longer than 1 h~~, ~~others producing a duration of action between 1–2 h~~, and ~~others lasting more than 2 h~~. ~~There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound~~<br><br><br>~~A limitation of this case report is that we did not have~~ a ~~urine sample available for additional NPS testing. Point~~-~~of-care DOA tests using urine to screen~~ for ~~misuse of multiple substances~~, ~~regularly include cannabis, amphetamines~~, ~~cocaine, opioids, benzodiazepines~~ and ~~methadone~~. ~~THC~~, ~~methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under~~ the ~~temperature of current e-cigarettes, while crack cocaine~~ is ~~hard~~ to ~~vaporise~~. ~~A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed~~ that ~~45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours~~<br><br>~~Moreover~~, ~~genetic makeup~~, ~~physiological conditions (age, gender and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drug~~<br><br>~~<br>In~~ the ~~present study, we performed various methods based on animal behavioral~~ testing ~~including FOB test for general behavioral observation, rotarod test, locomotor activity test for motor function evaluation, and water-maze test for learning/memory evaluation~~. ~~Known for its stability and consistent composition, this compound is frequently utilized by professionals seeking reliable materials for laboratory~~-~~based analytical studies. In this study, histopathological evaluation was performed to confirm~~ the ~~possibility~~ of ~~neurotoxicity~~ of ~~the tested substances by hematoxylin~~ and ~~eosin staining method from collected brain samples. In the present study~~, ~~we evaluated the neurotoxicity of two synthetic cannabinoids (~~JWH-~~081 and~~ JWH-210~~) through observation of various behavioral changes and analysis of histopathological changes using experimental mice with various doses~~ (~~0.1, 1, 5~~ mg/kg)~~. Selecting powder~~ JWH-~~210 demands careful evaluation~~ of ~~purity, legality,~~ and ~~supplier credibility~~. ~~Prices for research-grade~~ JWH-210 ~~vary significantly based on quantity,~~ purity, and ~~vendor complianc~~<br><br><br>~~JWH~~-~~210 Chemical Powder~~ offers a ~~reliable solution~~ for ~~laboratories seeking a compound that meets stringent requirements~~. ~~Researchers often require compounds that are consistent~~ and ~~dependable~~, and ~~this product delivers on both fronts~~. ~~Whether used in small~~-~~scale experiments or larger research projects~~, ~~the compound maintains its integrity under recommended storage conditions~~. ~~This ensures ease~~ of ~~handling and precise measurement during laboratory use~~. ~~Each batch undergoes detailed verification to ensure purity~~, ~~consistency~~, and ~~accuracy, making it suitable for controlled experimental environments. This study was supported by a grant~~ (~~13181MFDS654~~) ~~of the National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Kore~~<br><br><br>~~These synthetic cannabinoids~~ act ~~directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol~~ (~~Δ9-THC~~) ~~found in marijuana~~, ~~but~~ have ~~different chemical structures unrelated~~ to ~~Δ9-THC, different metabolism,~~ and ~~often greater toxicity~~ (~~Fantegrossi et al~~.~~, 2014~~). ~~Discriminative stimulus effects were tested in rats trained~~ to ~~discriminate Δ9-tetrahydrocannabinol~~ (~~3 mg/kg, 30-min pretreatment~~). 5F-MDMB-~~PINACA (also known as 5F-ADB~~, ~~5F-ADB-PINACA)~~, ~~MDMB-CHIMICA~~, ~~MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (~~also ~~known as FUB~~-~~AMB, MMB~~-~~FUBINACA) were tested for in vivo cannabinoid-like effects to assess~~ their ~~abuse liabilit~~<br><br><br>~~High resolution mass spectrometry such as LC-QTOF-MS allows~~ the ~~detection and identification of a broad spectrum of recreational drugs~~, including ~~new psychoactive substances. A point-of-care drugs of abuse~~ (~~DOA~~) test was ~~initially~~ performed on the ~~urine~~ of the ~~patient~~. ~~He confirmed drinking 750 ml energy drink without any further consumption of food and using an e-cigarette from Gaziantep~~, ~~Turkey 10 seconds before the onset of his first symptoms. He usually smokes a pack~~ of ~~cigarettes~~ a ~~day and sometimes smokes e-cigarettes. Combined with non-specific, transient symptoms, clinical recognition of SCRA intoxication~~ is ~~challenging .<br>Data availability <br>The intensity is plotted against the retention time for both chromatograms~~, ~~demonstrating the [https://cannabinoidsrc4f-adb~~.~~com/ JWH-210 powder] presence and elution profiles of nicotine and ADB-BUTINACA in the analysed vape liquid sample~~. ~~LC-QTOF-MS Chromatograms of Nicotine~~ (~~Top~~) ~~and ADB-BUTINACA~~ (~~Bottom~~) ~~in the Vape Liquid used by the patient~~. ~~The LC-QTOF-MS analysis showed~~ that ~~the e~~-~~liquid contained nicotine~~ and ADB~~-BUTINACA (Fig. 1). Because the point-of-care DOA test is generally not able to detect synthetic recreational drug~~ substances, the ~~liquid~~ of ~~the e~~-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient were reduced and the patient was discharged hom	+	Legal status <br>Briefly, the FOB test was comprised of several behavioral changes including catalepsy, traction, tremor, convulsion, exopthalmos, piloerection, salivation, lacrimation, diarrhea, skin coloration, pinna reflex, righting reflex, and death. The FOB test was performed using published procedures (Moser et al., 1989) with some modifications. However, because of their subjective properties, it is necessary to set up a more objective automated measurement to determine their neurotoxicity. However, there are only a couple of anecdotal reports suspecting the possibility of their neurotoxicity with no scientific evidence (Cohen et al., 2012; McGuinness and Newell, 2012; Harris and Brown, 2013; Hermanns et al., 2013<br><br><br>In summary, JWH-210 Chemical Powder stands out as a high-quality research compound designed for professionals who demand accuracy, consistency, and reliability. This commitment to 4F ADB quality makes it a trusted option for professionals who require dependable compounds for their work. From sourcing raw materials to final packaging, every stage of the process is monitored to ensure compliance with laboratory-grade expectations. This makes it an ideal choice for laboratories that prioritize both efficiency and compliance with research standards.<br>Key Features and Specifications to Evaluate <br>Higher prices often reflect rigorous quality control rather than markup alone. This compound is appropriate only for authorized professionals conducting lawful research or analysis. For legitimate applications, only fully characterized, independently tested JWH-210 [https://cannabinoidsrc4f-adb.com/ 4F ADB] should be considered.<br>How to Choose Powder JWH-210 <br>When learning how to choose powder JWH-210, the most critical factor is verifying high chemical purity (≥98%) from a reputable supplier with independent lab testing. We also demonstrated that JWH-210 administration resulted in the decrease of expression levels of T-cell activator including Cd3e, Cd3g, Cd74p31, and Cd74p41, while JWH-030 increased Cd3g levels. JWH-210 (10 mg/kg, 3 days, i.p.) is more likely to have cytotoxicity and reduce lymphoid organ weight than JWH-030 of ICR mice in vivo. Users are expected to handle the compound in accordance with all applicable regulations and safety guidelines within their jurisdiction. It is important to note that JWH-210 Chemical Powder is intended strictly for research and laboratory use only. Its reputation for purity and stability has contributed to its widespread use in controlled environments where precision is paramoun<br><br><br>LC separates the urine or blood sample and QTOF-MS provides high-resolution and accurate mass measurements for precise identification and structural elucidation of compounds. The LC-QTOF-MS method offers a more comprehensive and sensitive approach for drug detection, covering hundreds of recreational drugs, including NPS. Besides increasing the temperature to enlarge the drug aerolisation and bioavailability, one can elevate the flow rate of air through the e-cigarette and/or add a diluent . Of all e-cigarette users registered at this forum, 7.8 % vaped SCRAs . About 15 % of individuals registered at forums for drug users such as erowid.org who vaped cannabis have also vaped SRCAs. SCRAs belong, together with synthetic opioids, cathinones, amphetamines and hallucinogens to the new psychoactive substances (NPS) that are currently developed at high speed.<br>Data availabili<br><br><br>§ (3) of the Hungarian act of Forensic Experts (2016.XXIX), the data of the reported case can be utilized freely for scientific and educational purposes without special ethical permission. These results indicate that the simultaneous intoxication of SCRA and ethanol directly and exclusively caused the death of the two victims. The victims did not have any significant diseases that could have contributed to the outcome. Very limited data are available in the scientific literature about the possible effects of the combined consumption of SCRAs and ethanol. Several case reports describe that the presence of a little ng/mL (0.37–4.1) of SCRAs and a high—but not lethal—concentration of ethanol (1.45–2.7 g/L) directly and exclusively contributed to the death of the victim [24–27] (Table 2). The fact that 4F-MDMB-BINACA was not detected in postmortem urine samples is partly explained by the high rate of hepatic metabolism of SCRAs [11, 14, 22], but also suggests that the victims consumed 4F-MDMB-BINACA shortly before their death<br><br><br>Test 2 was performed everyday for 5 days after consecutive administration of the substances, including negative (vehicle) and positive (methamphetamine) controls. After the last administration, the first trial was performed. Morris water maze test was performed to evaluate the changes of learning and memory function through administration of the test substances. Generally, neurotoxicity of a substance is evaluated by animal behavioral aspects, i.e. functional observation battery (FOB) tests (O’Callaghan et al., 2014). Our results suggest that JWH-081 and JWH-210 may 4F ADB be neurotoxic substances through changing neuronal cell damages, especially in the core shell part of nucleus accumbens.<br>About Powder JWH-2

← Nächstältere Version		Version vom 4. Juni 2026, 08:55 Uhr
Zeile 1:		Zeile 1:
−	While the patient's symptoms strongly suggest the inhalation of ADB-BUTINACA, it is worth considering that these symptoms could also be attributed to nicotine exposure, as the symptoms partially overlap with known nicotine effect<br><br><br>The current study indicates that the test compounds produce locomotor depression similar to that of Δ9-THC, and fully substitute for the discriminative stimulus effects of Δ9-THC. In summary, these 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA have similar abuse liability as Δ9-tetrahydrocannabinol and should be controlled in a similar fashion. Much of the in vivo adb butinaca testing of the synthetic cannabinoid compounds have been pre-clinical studies focused on their cannabinoid-like effects or like the present study, focused on their abuse liability. There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016<br><br>There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016<br><br><br>Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (Gatch et al., 2014), whereas the potency of a recent set was 0.09±0.03 mg/kg (Gatch et al., 2018), and the potency of the current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound<br><br><br>In the present study, we performed various methods based on animal behavioral testing including FOB test for general behavioral observation, rotarod test, locomotor activity test for motor function evaluation, and water-maze test for learning/memory evaluation. Known for its stability and consistent composition, this compound is frequently utilized by professionals seeking reliable materials for laboratory-based analytical studies. In this study, histopathological evaluation was performed to confirm the possibility of neurotoxicity of the tested substances by hematoxylin and eosin staining method from collected brain samples. In the present study, we evaluated the neurotoxicity of two synthetic cannabinoids (JWH-081 and JWH-210) through observation of various behavioral changes and analysis of histopathological changes using experimental mice with various doses (0.1, 1, 5 mg/kg). Selecting powder JWH-210 demands careful evaluation of purity, legality, and supplier credibility. Prices for research-grade JWH-210 vary significantly based on quantity, purity, and vendor complianc<br><br><br>~~In summary,~~ JWH-210 Chemical Powder ~~stands out as~~ a ~~high~~-~~quality~~ research compound ~~designed for professionals who demand accuracy~~, consistency, and ~~reliability~~. This ~~commitment to adb butinaca quality makes it~~ a ~~trusted option for professionals who require dependable compounds for their work. From sourcing raw materials to final packaging~~, ~~every stage~~ of ~~the process is monitored to ensure compliance with laboratory-grade expectations. This makes it an ideal choice for laboratories that prioritize both efficiency~~ and ~~compliance with research standards.~~<br>~~Key Features and Specifications to Evaluate~~ <br>~~Higher prices~~ often ~~reflect rigorous quality control rather than markup alone~~. ~~This compound is appropriate only for authorized professionals conducting lawful research or analysis~~. ~~For legitimate applications, only fully characterized, independently~~ tested ~~JWH~~-~~210 [https:~~/~~/cannabinoidsrc4f~~-~~adb.com/ adb butinaca] should be considered~~.<br>~~How to Choose Powder JWH-210~~ <br>~~This dual~~-~~use nature underscores~~ the ~~importance~~ of ~~responsible sourcing and strict adherence to legal frameworks~~. ~~Forensic labs, public health researchers,~~ and ~~customs officials use authentic samples like JWH~~-~~210 to distinguish between legal and illegal compounds in seized materials~~. ~~For those seeking~~ a ~~dependable compound for analytical purposes, JWH-210 Chemical Powder provides~~ a ~~trusted~~ and ~~effective solution~~. ~~With its carefully controlled production process~~, ~~stable composition~~, ~~and secure packaging, it remains a valuable resource for laboratory-based research~~.<br>Is JWH-210 ~~Legal? <br>A total~~ of 2 and ~~3 methamphetamine treated mice fell from~~ the ~~spinning rod 30 min~~ and ~~2 hr after~~ the ~~administration, respectively~~. ~~After~~ the ~~first injection, 6 mice of the positive control group~~ (~~methamphetamine, 5 mg/kg, i~~.p.~~) showed loss~~ of ~~traction~~, of ~~which 4 showed tremor. Most~~ of the ~~abnormalities were normalized in synthetic cannabinoid treated mice although those abnormal behaviors remained in methamphetamine treated animals after 2 hr of administration~~. ~~Brain samples were prepared from~~ the ~~mice after~~ the ~~last administration~~ of ~~test substance~~	+	Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (Gatch et al., 2014), whereas the potency of a recent set was 0.09±0.03 mg/kg (Gatch et al., 2018), and the potency of the current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound<br><br><br>A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours<br><br>Moreover, genetic makeup, physiological conditions (age, gender and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drug<br><br><br>In the present study, we performed various methods based on animal behavioral testing including FOB test for general behavioral observation, rotarod test, locomotor activity test for motor function evaluation, and water-maze test for learning/memory evaluation. Known for its stability and consistent composition, this compound is frequently utilized by professionals seeking reliable materials for laboratory-based analytical studies. In this study, histopathological evaluation was performed to confirm the possibility of neurotoxicity of the tested substances by hematoxylin and eosin staining method from collected brain samples. In the present study, we evaluated the neurotoxicity of two synthetic cannabinoids (JWH-081 and JWH-210) through observation of various behavioral changes and analysis of histopathological changes using experimental mice with various doses (0.1, 1, 5 mg/kg). Selecting powder JWH-210 demands careful evaluation of purity, legality, and supplier credibility. Prices for research-grade JWH-210 vary significantly based on quantity, purity, and vendor complianc<br><br><br>JWH-210 Chemical Powder offers a reliable solution for laboratories seeking a compound that meets stringent requirements. Researchers often require compounds that are consistent and dependable, and this product delivers on both fronts. Whether used in small-scale experiments or larger research projects, the compound maintains its integrity under recommended storage conditions. This ensures ease of handling and precise measurement during laboratory use. Each batch undergoes detailed verification to ensure purity, consistency, and accuracy, making it suitable for controlled experimental environments. This study was supported by a grant (13181MFDS654) of the National Institute of Food and Drug Safety Evaluation, Ministry of Food and Drug Safety, Republic of Kore<br><br><br>These synthetic cannabinoids act directly at cannabinoid CB1 and CB2 receptors as does Δ9-tetrahydrocannabinol (Δ9-THC) found in marijuana, but have different chemical structures unrelated to Δ9-THC, different metabolism, and often greater toxicity (Fantegrossi et al., 2014). Discriminative stimulus effects were tested in rats trained to discriminate Δ9-tetrahydrocannabinol (3 mg/kg, 30-min pretreatment). 5F-MDMB-PINACA (also known as 5F-ADB, 5F-ADB-PINACA), MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA (also known as FUB-AMB, MMB-FUBINACA) were tested for in vivo cannabinoid-like effects to assess their abuse liabilit<br><br><br>High resolution mass spectrometry such as LC-QTOF-MS allows the detection and identification of a broad spectrum of recreational drugs, including new psychoactive substances. A point-of-care drugs of abuse (DOA) test was initially performed on the urine of the patient. He confirmed drinking 750 ml energy drink without any further consumption of food and using an e-cigarette from Gaziantep, Turkey 10 seconds before the onset of his first symptoms. He usually smokes a pack of cigarettes a day and sometimes smokes e-cigarettes. Combined with non-specific, transient symptoms, clinical recognition of SCRA intoxication is challenging .<br>Data availability <br>The intensity is plotted against the retention time for both chromatograms, demonstrating the [https://cannabinoidsrc4f-adb.com/ JWH-210 powder] presence and elution profiles of nicotine and ADB-BUTINACA in the analysed vape liquid sample. LC-QTOF-MS Chromatograms of Nicotine (Top) and ADB-BUTINACA (Bottom) in the Vape Liquid used by the patient. The LC-QTOF-MS analysis showed that the e-liquid contained nicotine and ADB-BUTINACA (Fig. 1). Because the point-of-care DOA test is generally not able to detect synthetic recreational drug substances, the liquid of the e-cigarette was thereafter screened using liquid chromatography-quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) on the Waters™ Xevo G3 QTOF MS system. After eating a light meal and drinking caffeinated sports drinks at the ER, the nausea complaints of the patient were reduced and the patient was discharged hom

← Nächstältere Version		Version vom 4. Juni 2026, 08:53 Uhr
Zeile 1:		Zeile 1:
−	A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the ~~temperature~~ of ~~current e~~-~~cigarettes~~, ~~while crack cocaine~~ is ~~hard~~ to ~~vaporise. A systematic review including data of 114 patients of which~~ the ~~majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours .~~<br>~~Data availability~~ <br>~~Moreover, a~~ study ~~conducted in~~ the ~~United Kingdom investigated components~~ of e-~~liquids in 112 samples originating from prisoners~~, ~~teenagers~~ and ~~test purchases of commercially available e-cigarettes taken between 2014 and 2021 . This is~~ the ~~first case report that describes the toxicological symptoms~~ of ~~vaping ADB~~-~~BUTINACA~~. ~~Results of the DOA test (including testing for amphetamines~~, ~~methamphetamines~~, ~~barbiturates~~, ~~benzodiazepines~~, ~~cocaine~~, ~~methadone, opioids, cannabis, tricyclic antidepressants) were available within 30 minutes~~ and ~~were all negative~~. ~~We report a case of an involuntary intoxication~~ of the ~~SCRA ADB-BUTINACA after vaping. There are several pitfalls~~ in ~~the detection~~ of ~~SCRA in samples taken from~~ the ~~patien<br><br><br>In general, the locomotor depressant and discriminative stimulus effects [https://cannabinoidsrc4f-adb.com/ 4F ADB]~~ have been ~~observed at doses that do not produce adverse~~ effects, ~~although tremors were observed upon handling in mice~~ that ~~received JWH~~-~~210~~ (~~Gatch~~ et al., 2016), and 5F-~~AMB produced sustained vocalization and convulsions in rats~~ (~~Gatch~~ et al., ~~2018). All~~ of the synthetic cannabinoids ~~tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC~~. ~~Subsequently~~, a ~~one-way analysis of variance was conducted on horizontal activity counts for~~ the ~~30-min period of maximal effect~~, ~~and planned comparisons were conducted for each dose against the vehicle control using single degree~~-of-~~freedom F tests. A two-way analysis of variance~~, ~~with dose as a between groups factor and time as a within subject factor~~, ~~was conducted on horizontal activity counts/10 min interval~~.<br>~~Michael B Gatch~~ <br>~~These findings are~~ in ~~agreement with earlier studies showing~~ the ~~synthetic cannabinoids substitute for the discriminative stimulus effects of Δ9-THC (see review by Wiley et al., 2017)~~. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. ~~As mentioned previously~~, short-~~onset~~ compounds have a greater abuse liability~~; further~~, compounds ~~that have fewer~~ adverse effects ~~while they are active are likely to be preferred~~. ~~All five~~ of the ~~compounds in~~ the ~~present study fully substituted~~ with a ~~pretreatment time~~ of ~~15 min~~, ~~suggesting~~ a ~~rapid onset~~ of ~~the discriminative stimulus effects~~. All of the cathinones fully substituted for the discriminative stimulus effects of Δ9-tetrahydrocannabinol (≥80% drug-appropriate responding). Because response suppression may compromise stimulus control, rats failing to ~~complete at least ten responses during the test session were excluded from the analysis~~ of ~~the discriminative stimulus effects of that dose of test compoun~~<br><br><br>~~Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2~~.11 and 2.~~49 g/L~~, ~~respectively). Forensic autopsy of both victims~~ was performed ~~four days after~~ the ~~time~~ of ~~death following~~ the ~~Recommendation No~~.R (99)3 of ~~the Council~~ of ~~Europe on medico~~-~~legal autopsies~~. ~~Elegans demonstrated the ability to form all of the in~~-~~vivo metabolites~~ and ~~has the potential to be used~~ as a ~~complementary model~~ to ~~predict and characterize human metabolites, as well as identifying possible drug toxicities~~ for ~~emerging SCBs~~. ~~Thus~~, ~~identification~~ of the ~~relevant urinary markers was based primarily upon the prevalence of the in~~-~~vivo metabolites instead of the metabolites ranking~~ that ~~was based upon % peak area abundance ratio~~. ~~Moreover~~, ~~genetic makeup~~, ~~physiological conditions (age~~, ~~gender 4F ADB~~ and ~~ethnicity)~~, ~~environmental influences (diet)~~ and ~~pathological factors (liver diseases~~, ~~diabetes~~, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for ~~each metabolite~~.<br>~~Data concerning~~ the ~~combined effects of SCRAs~~ and ~~other substances are highly limited~~, ~~which renders forensic evaluation~~ of ~~possible overdose cases difficult . The threshold SCRA concentration for fatal overdose can be estimated ng~~/~~mL level (0~~.~~37–4~~.~~1 ng/mL according to the reported cases~~) ~~in cases in~~ which 1.~~5–2.5 g/L~~ of ~~ethanol is present in~~ the ~~blood. The victims~~ were ~~brothers who were both found deceased~~ after ~~consuming 4F-MDMB-BINACA and ethanol~~. ~~These confusing shorter names~~ were ~~not scientifically adopted but were used by websites selling~~ the ~~drugs to~~ the ~~public. Monitoring metabolism~~ of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples. This article does not contain any studies with human participants or animals performed by any of the author	+	While the patient's symptoms strongly suggest the inhalation of ADB-BUTINACA, it is worth considering that these symptoms could also be attributed to nicotine exposure, as the symptoms partially overlap with known nicotine effect<br><br><br>The current study indicates that the test compounds produce locomotor depression similar to that of Δ9-THC, and fully substitute for the discriminative stimulus effects of Δ9-THC. In summary, these 5F-MDMB-PINACA, MDMB-CHIMICA, MDMB-FUBINACA, ADB-FUBINACA, and AMB-FUBINACA have similar abuse liability as Δ9-tetrahydrocannabinol and should be controlled in a similar fashion. Much of the in vivo adb butinaca testing of the synthetic cannabinoid compounds have been pre-clinical studies focused on their cannabinoid-like effects or like the present study, focused on their abuse liability. There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016<br><br>There is indication that at least some of the first-generation synthetic cannabinoids act at receptors other than cannabinoid CB1 and CB2 (Wiley et al., 2016), and a compound from the present study, 5F-MDMB-PINACA, was found to activate midbrain dopamine neurons, but not serotonin neurons (Asaoka et al., 2016<br><br><br>Tremors were observed in mice 30 minutes following 1 mg/kg AMB-FUBINACA in the present study. Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. Average potency of the discriminative stimulus effects of early compounds was 0.81±0.17 mg/kg (Gatch et al., 2014), whereas the potency of a recent set was 0.09±0.03 mg/kg (Gatch et al., 2018), and the potency of the current set is 0.05±0.01 mg/kg. Short-onset, short-acting compounds have a greater abuse liability, and long-acting compounds pose problems of long-acting adverse effects and interactions with other drugs. The duration of action of the synthetic cannabinoids tested using the 8-h protocol have varied widely, with some producing a duration of action no longer than 1 h, others producing a duration of action between 1–2 h, and others lasting more than 2 h. There seems to be a trend of newer synthetic cannabinoids being more potent than earlier compound<br><br><br>In the present study, we performed various methods based on animal behavioral testing including FOB test for general behavioral observation, rotarod test, locomotor activity test for motor function evaluation, and water-maze test for learning/memory evaluation. Known for its stability and consistent composition, this compound is frequently utilized by professionals seeking reliable materials for laboratory-based analytical studies. In this study, histopathological evaluation was performed to confirm the possibility of neurotoxicity of the tested substances by hematoxylin and eosin staining method from collected brain samples. In the present study, we evaluated the neurotoxicity of two synthetic cannabinoids (JWH-081 and JWH-210) through observation of various behavioral changes and analysis of histopathological changes using experimental mice with various doses (0.1, 1, 5 mg/kg). Selecting powder JWH-210 demands careful evaluation of purity, legality, and supplier credibility. Prices for research-grade JWH-210 vary significantly based on quantity, purity, and vendor complianc<br><br><br>In summary, JWH-210 Chemical Powder stands out as a high-quality research compound designed for professionals who demand accuracy, consistency, and reliability. This commitment to adb butinaca quality makes it a trusted option for professionals who require dependable compounds for their work. From sourcing raw materials to final packaging, every stage of the process is monitored to ensure compliance with laboratory-grade expectations. This makes it an ideal choice for laboratories that prioritize both efficiency and compliance with research standards.<br>Key Features and Specifications to Evaluate <br>Higher prices often reflect rigorous quality control rather than markup alone. This compound is appropriate only for authorized professionals conducting lawful research or analysis. For legitimate applications, only fully characterized, independently tested JWH-210 [https://cannabinoidsrc4f-adb.com/ adb butinaca] should be considered.<br>How to Choose Powder JWH-210 <br>This dual-use nature underscores the importance of responsible sourcing and strict adherence to legal frameworks. Forensic labs, public health researchers, and customs officials use authentic samples like JWH-210 to distinguish between legal and illegal compounds in seized materials. For those seeking a dependable compound for analytical purposes, JWH-210 Chemical Powder provides a trusted and effective solution. With its carefully controlled production process, stable composition, and secure packaging, it remains a valuable resource for laboratory-based research.<br>Is JWH-210 Legal? <br>A total of 2 and 3 methamphetamine treated mice fell from the spinning rod 30 min and 2 hr after the administration, respectively. After the first injection, 6 mice of the positive control group (methamphetamine, 5 mg/kg, i.p.) showed loss of traction, of which 4 showed tremor. Most of the abnormalities were normalized in synthetic cannabinoid treated mice although those abnormal behaviors remained in methamphetamine treated animals after 2 hr of administration. Brain samples were prepared from the mice after the last administration of test substance

← Nächstältere Version		Version vom 1. Juni 2026, 17:20 Uhr
Zeile 1:		Zeile 1:
−	~~Because response suppression may compromise stimulus control~~, ~~rats failing~~ to ~~complete~~ at ~~least ten responses during~~ the test ~~session were excluded from~~ the ~~analysis~~ of the ~~discriminative stimulus effects~~ of ~~that dose~~ of ~~test compoun~~<br><br><br>~~Inclusion in an NLM database does~~ not ~~imply endorsement of~~, ~~or agreement with, the contents by NLM or the National Institutes of Health~~. ~~It is illegal to sell~~, ~~distribute~~, ~~supply~~, ~~transport or trade~~ the ~~pharmaceutical drug under~~ the ~~Psychoactive Substances Act 2016~~. ~~The corresponding indole core analogue~~, 4F-~~MDMB~~-~~BICA (4F~~-~~MDMB~~-~~BUTICA)~~, ~~has also been widely sold~~ as a ~~designer~~ drug ~~by chemical providers~~ on the ~~internet, first being identified~~ in ~~May 2020~~. ~~It has been used as an~~ active ~~ingredient~~ in ~~synthetic cannabis products and sold as~~ a ~~designer drug since late 2018~~. 4F-~~MDMB-BINACA~~ (~~also known as MDMB-4F-BINACA using systematic EMCDDA nomenclature or 4F-MDMB~~-~~BUTINACA~~) ~~is an indazole-based synthetic cannabinoid~~ from the ~~indazole-3-carboxamide family.<br>Fig.~~ <br><br><br>Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L, respectively). Forensic autopsy of both victims was performed four days after the time of death following the Recommendation No.R (99)3 of the Council of Europe on medico-legal autopsies. Elegans demonstrated the ability to form all of the in-vivo metabolites and has the potential to be used as a complementary model to predict and characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs. Thus, identification of the relevant urinary markers was based primarily upon the prevalence of the in-vivo metabolites instead of the metabolites ranking that was based upon % peak area abundance ratio. Moreover, genetic makeup, physiological conditions (age, gender ~~5CLADBA~~ and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite.<br>~~Victim B also brought "something resembling a drug" (unrecognizable by Witness A) from his cousin (Witness B) in a cigarette box~~ and ~~mixed this substance with their tobacco~~. The ~~half-maximal effective~~ concentration ~~(EC50) of 4F-MDMB-BINACA is 5.69 nM (2.76–11.0 nM) on CB1, and 0.69 nM~~ (0.~~30–1~~.~~56 nM) on CB2, in vitro half-life (t1~~/2) is 10.27 min . It is usually available as a powder, liquid (vapor fluid), or herbal plant mixtur<br><br>Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans <br>This might be due to the ~~low activity of numerous metabolizing enzymes resulting in lower drug biotransformation . HepG2 model detected the major ester hydrolysis metabolite of 4F-MDMB-BINACA~~ in ~~abundance but the rest of the metabolites were found~~ in ~~a small amount~~. ~~Elegans and HLM models detected all of the in-vivo metabolites (100%), whilst HepG2 cells detected 7 out of the 8 in-vivo metabolites (87~~.5~~%). Hence, structural elucidation could not be confirmed unless a reference standard~~ is ~~made availabl<br><br><br>Locomotor activity~~ in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the ~~CB1 receptor~~. ~~Tremors~~ were ~~not observed following AMB~~-~~FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10~~-fold lower than the dose that produced tremors in the mice. AMB-FUBINACA has been implicated in severe adverse effects in recreational users (Adams et al., 2017; Hamilton et al., 2017), which suggests that the range between behaviorally active and ~~toxic doses of AMB-FUBINACA is narrow~~. Following that line of reasoning, it should also be noted that some of the more recent compounds produced non-linear dose-effect curves and one compound produced an inverted U-shaped dose-effect, such that intermediate dose fully substituted, but ~~higher doses did not (Gatch and Forster, 2018). All of~~ the ~~compounds identified as available on the recreational market and submitted~~ to ~~our laboratory by~~ the US Drug Enforcement Agency for testing have fully substituted at some dose (Gatch and Forster 2014, 2015, 2016, 2018); however; it is important to note that not all structural congeners are active (Wiley et al.~~, 2012<br><br><br>Taken together these data further confirmed the structure elucidation~~ of ~~B16. The precursor ion m/z 276 (B1) detected, which was 74 Da lower than that for the~~ 4F-MDMB-BINACA ~~ester hydrolysis metabolite (B22)~~, ~~indicated N-dealkylation of B22~~. The precursor ion m/z 348 and product ion detected at m/z 217 (B2) identified was 2 Da less than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicating oxidative defluorination (loss of fluorine with ~~addition~~ of ~~hydroxy [https://cannabinoidsrc4f-adb.com/ 5CLADBA] group~~	+	A limitation of this case report is that we did not have a urine sample available for additional NPS testing. Point-of-care DOA tests using urine to screen for misuse of multiple substances, regularly include cannabis, amphetamines, cocaine, opioids, benzodiazepines and methadone. THC, methamphetamine, SRCA, lysergic acid diethylamide (LSD), gamma-hydroxybutyrate (GHB) and ketamine are likely to become volatile under the temperature of current e-cigarettes, while crack cocaine is hard to vaporise. A systematic review including data of 114 patients of which the majority was intoxicated due to SCRA smoking revealed that 45 % of the patients who present at the ER after an intoxication due to SCRA smoking recovered within 24 hours .<br>Data availability <br>Moreover, a study conducted in the United Kingdom investigated components of e-liquids in 112 samples originating from prisoners, teenagers and test purchases of commercially available e-cigarettes taken between 2014 and 2021 . This is the first case report that describes the toxicological symptoms of vaping ADB-BUTINACA. Results of the DOA test (including testing for amphetamines, methamphetamines, barbiturates, benzodiazepines, cocaine, methadone, opioids, cannabis, tricyclic antidepressants) were available within 30 minutes and were all negative. We report a case of an involuntary intoxication of the SCRA ADB-BUTINACA after vaping. There are several pitfalls in the detection of SCRA in samples taken from the patien<br><br><br>In general, the locomotor depressant and discriminative stimulus effects [https://cannabinoidsrc4f-adb.com/ 4F ADB] have been observed at doses that do not produce adverse effects, although tremors were observed upon handling in mice that received JWH-210 (Gatch et al., 2016), and 5F-AMB produced sustained vocalization and convulsions in rats (Gatch et al., 2018). All of the synthetic cannabinoids tested in the present study fully substituted for the discriminative stimulus effects of Δ9-THC. Subsequently, a one-way analysis of variance was conducted on horizontal activity counts for the 30-min period of maximal effect, and planned comparisons were conducted for each dose against the vehicle control using single degree-of-freedom F tests. A two-way analysis of variance, with dose as a between groups factor and time as a within subject factor, was conducted on horizontal activity counts/10 min interval.<br>Michael B Gatch <br>These findings are in agreement with earlier studies showing the synthetic cannabinoids substitute for the discriminative stimulus effects of Δ9-THC (see review by Wiley et al., 2017). Pretreatment times and dose ranges for the drug discrimination assay were selected based on the time of peak depression in the locomotor activity assay in mice. As mentioned previously, short-onset compounds have a greater abuse liability; further, compounds that have fewer adverse effects while they are active are likely to be preferred. All five of the compounds in the present study fully substituted with a pretreatment time of 15 min, suggesting a rapid onset of the discriminative stimulus effects. All of the cathinones fully substituted for the discriminative stimulus effects of Δ9-tetrahydrocannabinol (≥80% drug-appropriate responding). Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during the test session were excluded from the analysis of the discriminative stimulus effects of that dose of test compoun<br><br><br>Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L, respectively). Forensic autopsy of both victims was performed four days after the time of death following the Recommendation No.R (99)3 of the Council of Europe on medico-legal autopsies. Elegans demonstrated the ability to form all of the in-vivo metabolites and has the potential to be used as a complementary model to predict and characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs. Thus, identification of the relevant urinary markers was based primarily upon the prevalence of the in-vivo metabolites instead of the metabolites ranking that was based upon % peak area abundance ratio. Moreover, genetic makeup, physiological conditions (age, gender 4F ADB and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite.<br>Data concerning the combined effects of SCRAs and other substances are highly limited, which renders forensic evaluation of possible overdose cases difficult . The threshold SCRA concentration for fatal overdose can be estimated ng/mL level (0.37–4.1 ng/mL according to the reported cases) in cases in which 1.5–2.5 g/L of ethanol is present in the blood. The victims were brothers who were both found deceased after consuming 4F-MDMB-BINACA and ethanol. These confusing shorter names were not scientifically adopted but were used by websites selling the drugs to the public. Monitoring metabolism of synthetic cannabinoid 4F-MDMB-BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line, fungus, liver microsomes and confirmed using urine samples. This article does not contain any studies with human participants or animals performed by any of the author

← Nächstältere Version		Version vom 30. Mai 2026, 18:46 Uhr
Zeile 1:		Zeile 1:
−	Taken together these data further confirmed the structure elucidation of B16. The precursor ion m/z 276 (B1) detected, which was 74 Da lower than that for the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicated N-dealkylation of B22. The precursor ion m/z 348 and product ion detected at m/z 217 (B2) identified was 2 Da less than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicating oxidative defluorination (loss of fluorine with addition of hydroxy [https://cannabinoidsrc4f-adb.com/ JWH-210 powder] group<br><br><br>Effects of individual doses were compared to the vehicle control value using a priori contrasts. Response-rate data were analyzed by one-way repeated-measure analysis of variance. Percent drug-appropriate responding was shown only if at JWH-210 powder least three rats completed the first fixed ratio, whereas all rats are shown for the response rate dat<br><br><br>Acute kidney damage and even kidney failure have been reported following use of synthetic cannabinoids (Davidson, et al., 2017). One recent study has looked at other mechanisms of action in some of the older synthetic cannabinoids and reported that some produced varying amounts of activity at sites which are related to cardiotoxicity and heart disease (Wiley et al., 2016). It is not known whether the increased toxicity is due only to activation of CB1 cannabinoid receptors more strongly than Δ9-THC or whether these "super-strength" cannabinoids produce effects at other receptors. A major cause of concern is that some of the more recently seen synthetic cannabinoids are more likely to produce extremely toxic effects than the older synthetics (Tai and Fantegrossi, 2017<br><br>Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during the test session were excluded from the analysis of the discriminative stimulus effects of that dose of test compoun<br><br><br>~~A total~~ of ~~2 and 3 methamphetamine treated mice fell from~~ the ~~spinning rod 30 min and 2 hr after~~ the ~~administration~~, ~~respectively~~. ~~After the first injection~~, ~~6 mice of the positive control group~~ (~~methamphetamine~~, ~~5 mg/kg~~, i.p.) ~~showed loss of traction, of which 4 showed tremor. Most of the abnormalities were normalized in~~ synthetic cannabinoid ~~treated mice although those abnormal behaviors remained in methamphetamine treated animals after 2 hr of administration. Brain samples were prepared~~ from the ~~mice after the last administration of test substance~~<br><br>~~Legal status~~ <br>~~Briefly~~, the ~~FOB test was comprised~~ of ~~several behavioral changes including catalepsy, traction, tremor, convulsion, exopthalmos, piloerection, salivation, lacrimation, diarrhea, skin coloration, pinna reflex, righting reflex, and~~ death. ~~The FOB test was performed using published procedures~~ (~~Moser et al., 1989~~) ~~with some modifications~~. ~~However, because~~ of ~~their subjective properties, it is necessary~~ to ~~set up~~ a ~~more objective automated measurement~~ to ~~determine their neurotoxicity~~. ~~However~~, ~~there are only a couple~~ of ~~anecdotal reports suspecting~~ the ~~possibility~~ of ~~their neurotoxicity with no scientific evidence~~ (~~Cohen et al.~~, ~~2012; McGuinness~~ and ~~Newell~~, ~~2012; Harris~~ and ~~Brown~~, ~~2013; Hermanns et al~~.~~, 2013~~<br>~~<br><br>Separation~~ of ~~compounds was performed on a~~ 2.~~1 mm×100 mm~~, 1.~~7 JWH-210 powder μm particle size ACQUITY Torus™ DIOL analytical column~~ (~~Waters) with guard cartridge~~. ~~Measurements were performed by an ACQUITY UPC2 supercritical fluid chromatography system (Waters~~) ~~coupled with a Xevo TQ~~-~~S Triple Quadrupole Mass Spectrometer~~ (~~Waters~~). ~~During the death scene examination~~, ~~multiple cigarette butts without filters were found in an ashtray; also found were alcohol bottles~~, ~~an unopened box~~ of ~~nebivolol~~-~~containing drug~~, and ~~18 g of unrecognizable herbal residue in a cigarette box.~~<br>Data concerning the combined effects of SCRAs and other substances are highly limited, which renders forensic evaluation of possible overdose cases difficult . The threshold SCRA concentration for fatal overdose can be ~~estimated ng/mL level (0.37–4.1 ng/mL according~~ to the ~~reported cases)~~ in ~~cases in which 1~~.~~5–2.5 g/L~~ of ~~ethanol is present in the blood. The victims were brothers who were both found deceased after consuming~~ 4F-MDMB-BINACA ~~and ethanol. These confusing shorter names were not scientifically adopted~~ but ~~were used by websites selling~~ the ~~drugs to~~ the ~~public~~. ~~Monitoring metabolism~~ of ~~synthetic cannabinoid 4F~~-~~MDMB~~-~~BINACA via high-resolution mass spectrometry assessed in cultured hepatoma cell line~~, ~~fungus, liver microsomes and~~ confirmed ~~using urine samples. This article does not contain any studies with human participants or animals performed by any of the author~~<br><br><br>LC-~~QTOF~~-~~MS represents a significant advancement in~~ the ~~field of~~ drug ~~detection~~, ~~offering higher sensitivity~~, ~~specificity, and a broader spectrum of detectable substances. Despite all negative results~~ in the ~~point~~-~~of-care test for~~ recreational ~~drugs~~, the ~~liquid chromatography-quadrupole time~~-of~~-flight mass spectrometry (LC-QTOF-MS) analysis showed~~ that ~~the liquid~~ of the e-~~cigarette contained ADB~~-~~BUTINACA~~, ~~a synthetic cannabinoid~~. ~~We report a 27-year-old man who was admitted~~ to the ~~emergency room because of sudden JWH-210 powder headache~~, ~~nausea~~, ~~vertigo~~, ~~red eyes and palpitations. Synthetic cannabinoids are gaining popularity globally and detection~~ is not ~~commonly available~~.<br>~~Data availability~~ <br>~~When clinical presentation and~~/~~or initial DOA testing results are inconclusive~~, ~~additional testing with LC~~-~~QTOF~~-~~MS can be valuable and is recommended~~. ~~SCRAs~~ and ~~other NPS may not be~~ detected ~~by point~~-of-~~care DOA tests. In this case~~, ~~the point-~~of-~~care DOA urine screening was not able to detect the synthetic cannabinoid ADB-BUTINAC~~	+	Because response suppression may compromise stimulus control, rats failing to complete at least ten responses during the test session were excluded from the analysis of the discriminative stimulus effects of that dose of test compoun<br><br><br>Inclusion in an NLM database does not imply endorsement of, or agreement with, the contents by NLM or the National Institutes of Health. It is illegal to sell, distribute, supply, transport or trade the pharmaceutical drug under the Psychoactive Substances Act 2016. The corresponding indole core analogue, 4F-MDMB-BICA (4F-MDMB-BUTICA), has also been widely sold as a designer drug by chemical providers on the internet, first being identified in May 2020. It has been used as an active ingredient in synthetic cannabis products and sold as a designer drug since late 2018. 4F-MDMB-BINACA (also known as MDMB-4F-BINACA using systematic EMCDDA nomenclature or 4F-MDMB-BUTINACA) is an indazole-based synthetic cannabinoid from the indazole-3-carboxamide family.<br>Fig. <br><br><br>Our findings revealed that both victims consumed large amounts of alcohol preceding their deaths (blood alcohol concentrations (BAC) were 2.11 and 2.49 g/L, respectively). Forensic autopsy of both victims was performed four days after the time of death following the Recommendation No.R (99)3 of the Council of Europe on medico-legal autopsies. Elegans demonstrated the ability to form all of the in-vivo metabolites and has the potential to be used as a complementary model to predict and characterize human metabolites, as well as identifying possible drug toxicities for emerging SCBs. Thus, identification of the relevant urinary markers was based primarily upon the prevalence of the in-vivo metabolites instead of the metabolites ranking that was based upon % peak area abundance ratio. Moreover, genetic makeup, physiological conditions (age, gender 5CLADBA and ethnicity), environmental influences (diet) and pathological factors (liver diseases, diabetes, and obesity) would further complicate the metabolism of drugs. It should be noted that % peak area abundance ratios do not necessarily reflect absolute concentrations due to differences in ionization capacity and matrix effects bias for each metabolite.<br>Victim B also brought "something resembling a drug" (unrecognizable by Witness A) from his cousin (Witness B) in a cigarette box and mixed this substance with their tobacco. The half-maximal effective concentration (EC50) of 4F-MDMB-BINACA is 5.69 nM (2.76–11.0 nM) on CB1, and 0.69 nM (0.30–1.56 nM) on CB2, in vitro half-life (t1/2) is 10.27 min . It is usually available as a powder, liquid (vapor fluid), or herbal plant mixtur<br><br>Metabolic Profile of Synthetic Cannabinoids 5F-PB-22, PB-22, XLR-11 and UR-144 by Cunninghamella elegans <br>This might be due to the low activity of numerous metabolizing enzymes resulting in lower drug biotransformation . HepG2 model detected the major ester hydrolysis metabolite of 4F-MDMB-BINACA in abundance but the rest of the metabolites were found in a small amount. Elegans and HLM models detected all of the in-vivo metabolites (100%), whilst HepG2 cells detected 7 out of the 8 in-vivo metabolites (87.5%). Hence, structural elucidation could not be confirmed unless a reference standard is made availabl<br><br><br>Locomotor activity in mice was tested to screen for locomotor depressant effects and to identify behaviorally-active dose ranges and times of peak effect. Previous studies have demonstrated that these compounds have chemical structures similar to synthetic cannabinoids known to have substantial abuse liability and act at the CB1 receptor. Tremors were not observed following AMB-FUBINACA during the drug discrimination study, but the maximum dose tested was only 0.1 mg/kg, which is 10-fold lower than the dose that produced tremors in the mice. AMB-FUBINACA has been implicated in severe adverse effects in recreational users (Adams et al., 2017; Hamilton et al., 2017), which suggests that the range between behaviorally active and toxic doses of AMB-FUBINACA is narrow. Following that line of reasoning, it should also be noted that some of the more recent compounds produced non-linear dose-effect curves and one compound produced an inverted U-shaped dose-effect, such that intermediate dose fully substituted, but higher doses did not (Gatch and Forster, 2018). All of the compounds identified as available on the recreational market and submitted to our laboratory by the US Drug Enforcement Agency for testing have fully substituted at some dose (Gatch and Forster 2014, 2015, 2016, 2018); however; it is important to note that not all structural congeners are active (Wiley et al., 2012<br><br><br>Taken together these data further confirmed the structure elucidation of B16. The precursor ion m/z 276 (B1) detected, which was 74 Da lower than that for the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicated N-dealkylation of B22. The precursor ion m/z 348 and product ion detected at m/z 217 (B2) identified was 2 Da less than the 4F-MDMB-BINACA ester hydrolysis metabolite (B22), indicating oxidative defluorination (loss of fluorine with addition of hydroxy [https://cannabinoidsrc4f-adb.com/ 5CLADBA] group